Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Authors:	Chatterjee Saurav Maitra Subhankar Chakraborty Anasua

Institution:	Maimonides Medical Center, Brooklyn, NY;University of Connecticut, Farmington, CT

Abstract:

Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录！